Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereof

Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereof

US Patent 10981976 · Granted Apr 20, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-influenza neuraminidase monoclonal antibodies and uses thereof2025
Anti-influenza neuraminidase monoclonal antibodies and uses thereof2024
Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility2022
Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhib2022
Broadly neutralizing anti-influenza human monoclonal antibody and uses thereof2021
Methods and compositions useful in generating non canonical CD8+ T cell response2021
Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility2020
Use of bisphosphonates as HIV/AIDS adjunctive treatment2017
Method of inducing a T lymphocyte response using T-cell immunogens derived from 2017
Methods of inhibiting viral replication and improving T cell function employing 2016
T-cell immunogens derived from anti-viral proteins and methods of using same2015
Method of detecting antigen-specific T lymphocytes2008